SoftBank Vision Fund
SoftBank Vision Fund is one of the world's largest technology-focused investment funds, backed by SoftBank Group and sovereign wealth funds. The fund has made significant investments in healthcare and life sciences, including companies at the intersection of AI, genomics, and drug discovery.
Website
https://visionfund.comLocation
Tokyo, Japan & London, UK
Founded
2017
AUM
$100B+
Investment Range
$100M - $1B+
Portfolio Companies
2
Focus
generalist
Fund Stages
series-b, series-c, growth
Investment Thesis
SoftBank Vision Fund invests in transformative technology companies that can achieve massive scale. In healthcare, they focus on companies leveraging AI, data, and technology platforms to transform drug discovery, healthcare delivery, and patient outcomes. They seek category-defining companies with the potential to become global leaders.
Team
Partners / Managing Directors (Health Focus)
- Masayoshi Son - Founder & CEO, SoftBank Group
- Rajeev Misra - Former CEO, SoftBank Vision Fund
- Deep Nishar - Senior Managing Partner
Other Key Team Members
- Munish Varma - Managing Partner
- Yanni Pipilis - Managing Partner
Focus Areas
- AI in Healthcare
- Digital Health Platforms
- Drug Discovery & Development
- Healthcare Technology
- Genomics & Precision Medicine
- Longevity & Aging
Notable Portfolio Companies (Healthcare/Biotech)
- Metsera - Obesity therapeutics ($290M, April 2024)
- Deep Genomics - AI-driven drug discovery ($180M Series C)
- Tempus - AI-enabled precision medicine
- Roivant Sciences - Drug development platform
- Vir Biotechnology - Infectious disease therapeutics
- Relay Therapeutics - AI-driven drug design
Notable Exits
- Vir Biotechnology - IPO (2019, NASDAQ: VIR)
- Relay Therapeutics - IPO (2020, NASDAQ: RLAY)
- Guardant Health - IPO (NASDAQ: GH)
Sources
- SoftBank Vision Fund website: https://visionfund.com
- Crunchbase: https://www.crunchbase.com/organization/softbank-vision-fund
- Bloomberg, Financial Times coverage